Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age

Rajan Wadhawan, William Oh, Betty R. Vohr, Abhik Das, Edward F. Bell, Abbott Laptook, Seetha Shankaran, Barbara J. Stoll, Michele C. Walsh, Rose Higgins

Archives of Disease in Childhood Fetal & Neonatal · 2012 · 58 citations · 21 references

DOIFull text

Open access

Abstract

Indometacin used for IVH prophylaxis and ANS were not associated with the occurrence of SIP in ELBW infants. Indometacin used for treatment of symptomatic PDA was however associated with an increased risk of SIP. ELBW infants with SIP have an increased risk of poor neurodevelopmental outcomes.

References

21